pomalidomide has been researched along with HIV Coinfection in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| George, J; Goncalves, P; Lurain, K; Polizzotto, MN; Ramaswami, R; Steinberg, SM; Uldrick, TS; Whitby, D; Widell, A; Wyvill, KM; Yarchoan, R | 1 |
| Jensen, SMR; Krug, LT; Lurain, K; Polizzotto, MN; Ramaswami, R; Sereti, I; Shoemaker, G; Singh, A; Uldrick, TS; Wyvill, KM; Yarchoan, R | 1 |
| Ambinder, R; Cheever, M; Ekwede, I; George, J; Goncalves, PH; Gulley, JL; Lurain, K; Mangusan, R; Ramaswami, R; Uldrick, TS; Wang, HW; Widell, A; Yarchoan, R | 1 |
| Aleman, K; Bevans, M; Figg, WD; Goncalves, PH; Khetani, V; Maldarelli, F; Marshall, V; Peer, CJ; Polizzotto, MN; Sereti, I; Steinberg, SM; Uldrick, TS; Whitby, D; Wyvill, KM; Yarchoan, R; Zeldis, JB | 1 |
| Aerts, JL; Allard, SD; De Keersmaecker, B; Lacor, P; Schots, R; Thielemans, K | 1 |
3 trial(s) available for pomalidomide and HIV Coinfection
| Article | Year |
|---|---|
Safety, Activity, and Long-term Outcomes of Pomalidomide in the Treatment of Kaposi Sarcoma among Individuals with or without HIV Infection.
Topics: Anticoagulants; Herpesvirus 8, Human; HIV Infections; Humans; Sarcoma, Kaposi; Thalidomide; Venous Thromboembolism | 2022 |
Immunophenotypic analysis in participants with Kaposi sarcoma following pomalidomide administration.
Topics: CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; HIV Infections; Humans; Leukocytes, Mononuclear; Lymphocyte Activation; Sarcoma, Kaposi; T-Lymphocyte Subsets | 2023 |
Pomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II Study.
Topics: Administration, Oral; Adult; Aged; Angiogenesis Inhibitors; HIV Infections; Humans; Male; Middle Aged; Quality of Life; Sarcoma, Kaposi; Thalidomide; Treatment Outcome | 2016 |
2 other study(ies) available for pomalidomide and HIV Coinfection
| Article | Year |
|---|---|
Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin's lymphoma.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Female; HIV Infections; Humans; Immune Checkpoint Inhibitors; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Progression-Free Survival; Retrospective Studies; Thalidomide; Time Factors | 2021 |
Expansion of polyfunctional HIV-specific T cells upon stimulation with mRNA electroporated dendritic cells in the presence of immunomodulatory drugs.
Topics: CD8-Positive T-Lymphocytes; Cells, Cultured; Dendritic Cells; Electroporation; gag Gene Products, Human Immunodeficiency Virus; HIV Infections; HIV-1; Humans; Immunologic Factors; Lenalidomide; nef Gene Products, Human Immunodeficiency Virus; RNA, Messenger; Species Specificity; Thalidomide | 2012 |